Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús Duque-Afonso

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cancer Cell|March 22, 2014
The AML salad bowlJesús Duque-Afonso, Michael L Cleary
Haematologica|May 29, 2025
"Dexamethasing" acute myeloid leukemia: new opportunities for an "old" drugJesús Duque-Afonso, Julian List, Michael Lübbert
Oncogene|July 31, 2021
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanismsKai Rejeski, Jesús Duque-Afonso, Michael Lübbert
Plos One|November 21, 2015
Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In MiceJesús Duque-Afonso, Kevin S Smith, Michael L Cleary
British Journal of Haematology|April 15, 2011
Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiationJesús Duque-Afonso, Leticia Solari, Aitomi Essig, et al.
Epigenetics|June 23, 2021
The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapyRieke Schröder, Anna-Lena Illert, Thalia Erbes, et al.
Leukemia Research|April 13, 2010
The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cellsMaika Almstedt, Nadja Blagitko-Dorfs, Jesús Duque-Afonso, et al.
European Journal of Haematology|October 10, 2024
Reduced Intensity Conditioning Prior Autologous Stem Cell Transplantation in Elderly DLBCL PatientsTim Strüßmann, Philipp Hermes, Gabriele Ihorst, et al.
Cancers|July 27, 2022
Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell TransplantationMiguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, et al.
Plos One|October 12, 2013
Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostatNadja Blagitko-Dorfs, Yi Jiang, Jesús Duque-Afonso, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cancer Cell|March 22, 2014
The AML salad bowlJesús Duque-Afonso, Michael L Cleary
Haematologica|May 29, 2025
"Dexamethasing" acute myeloid leukemia: new opportunities for an "old" drugJesús Duque-Afonso, Julian List, Michael Lübbert
Oncogene|July 31, 2021
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanismsKai Rejeski, Jesús Duque-Afonso, Michael Lübbert
Plos One|November 21, 2015
Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In MiceJesús Duque-Afonso, Kevin S Smith, Michael L Cleary
British Journal of Haematology|April 15, 2011
Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiationJesús Duque-Afonso, Leticia Solari, Aitomi Essig, et al.
Epigenetics|June 23, 2021
The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapyRieke Schröder, Anna-Lena Illert, Thalia Erbes, et al.
Leukemia Research|April 13, 2010
The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cellsMaika Almstedt, Nadja Blagitko-Dorfs, Jesús Duque-Afonso, et al.
European Journal of Haematology|October 10, 2024
Reduced Intensity Conditioning Prior Autologous Stem Cell Transplantation in Elderly DLBCL PatientsTim Strüßmann, Philipp Hermes, Gabriele Ihorst, et al.
Cancers|July 27, 2022
Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell TransplantationMiguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, et al.
Plos One|October 12, 2013
Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostatNadja Blagitko-Dorfs, Yi Jiang, Jesús Duque-Afonso, et al.
Pageof 4